🔥Hot off the Press!🔥 Just published in @CIDJournal, our 2024 update to the @HIVMA@IDSAInfo HIV Primary Care Guidance! Please share widely.
https://t.co/3ixEE0V0nS
The mission of the #RyanWhite program is to provide comprehensive care for ALL people with #HIV. @HIVMA@LambdaLegal@aahivmcomm & @IAPAC went to federal court to fight for the ability of clinicians to provide care for transgender people with HIV. ALL means ALL. @IDSAInfo
This week, Lambda Legal & HIV advocates brought the case for equitable care into the courtroom.
See comments from HIVMA Past Chair @drmt on protecting access to comprehensive care, including gender-affirming care, for transgender PWH through Ryan White: https://t.co/lTMaaUUC7e
Direct Initiation of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV and Suboptimal Virologic Suppression: A Randomized Trial
✅ Just Accepted
⭐ Editor's Choice
🔗 https://t.co/AxlO8Rimyn
Today, the AMA joined the Vaccine Integrity Project in announcing the completion of an independent, vaccine evidence review process for the 2026–27 respiratory virus season.
The Vaccine Integrity Project conducted a thorough scientific review of RSV, flu, and COVID-19 vaccines — examining the risks and benefits.
The evidence showed that immunizations against these respiratory viruses continue to provide meaningful protection against severe illness, hospitalization and death, with no new safety concerns in comparative studies with currently recommended immunizations.
The evidence reviews helped inform new 2026–27 recommendations released by leading medical societies. The AMA also created new resources to help clinicians and patients put the latest evidence and recommendations into practice.
Now more than ever, the public deserves clear, credible vaccine guidance grounded in the best available evidence and developed through a transparent process.
Learn more: https://t.co/ht7vH4v8bU
IDSA & @HIVMA applaud Congress for its swift, overwhelmingly bipartisan approval of a continuing resolution to fund the government and block OMB from implementing its proposed “Regulation for Federal Financial Assistance” until 12/11.
Our statement: https://t.co/EL4Szmgvdl
Updated IDSA Guidelines out now! IDSA has released updated evidence-based guidelines on COVID-19, influenza, and RSV vaccinations in the immunocompromised population.
Access the guidelines: https://t.co/YrXkPITLX5
Our press release: https://t.co/bQC3ANb66o
Respiratory season vaccines are coming. Look to your medical providers, pharmacists, medical associations, and local and state health departments for guidance. Skip the noise on social media.
Our team, our local program partners, and every operational partner who helps make this program possible each month are heartbroken at the loss of our founder, Dolly Parton. (cont.)
I want to emphasize that all the information that was shared Monday at the White House should be totally disregarded. It is dangerous. And hopefully parents will understand that was not a responsible sharing of information.
For the full discussion, listen to episode 215⬇️
Whole Foods has recalled more guacamole, dips and other food products over a link to a salmonella outbreak. Here's the full list. https://t.co/zZ9bjFK547
This virtual roundtable convened experts in N. gonorrhoeae epidemiology, public health prevention programs, novel diagnostics, genomics, and therapeutics.
Watch the roundtable and read the article: https://t.co/juDZhgi4gH
Testosterone is real medicine for men who genuinely can't make enough (Klinefelter, a pituitary problem, cancer treatment). For a man whose level is normal, it's risk with no proven benefit: clots, infertility, breast tissue.
Save & share, read free: https://t.co/wyROLaLJi8
Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistance
🔁 Repost
https://t.co/eIkePzBEZr
Important new statement from the @HIVMA@IDSAInfo#HIV Primary Care Guidance panel. Our panel cannot recommend relying on CDC ACIP vaccine recommendations after June 2025. We recommend @HHS OI Guidelines and professional society guidelines instead.
Yes, vaccines save lives, but if you insist on asking, they also save money @IDSAInfo@PIDSociety
Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation - https://t.co/EtllzSmKzO
🚨Colleagues in infectious diseases, public health, emergency medicine, global health, and related fields:
Myself, Deb Houry, Anne Schuchat and @Craig_A_Spencer with the support of @IDSAInfo have drafted an open letter to Congress regarding the proposed use of third-country facilities for the quarantine, isolation, or treatment of Americans potentially exposed to or infected with Ebola virus disease.
The letter outlines concerns related to standards of care, access to advanced supportive and critical care, oversight and accountability, patient rights and well-being, and the potential diversion of resources from outbreak response efforts.
We invite you to review the letter and consider signing on by Thursday, 5 PM ET.
✍️ Sign on here: https://t.co/aNrlZPKs73
The White House’s proposed rule would fundamentally alter the U.S. approach to science, drive away multitudes of researchers and eliminate the promise of lifesaving cures for decades to come.
Our full response: https://t.co/OgTGddcpU0
Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral antiviral Ensitrelvir, commercially known as Xocova, for the preventive treatment of individuals who have been exposed to COVID-19. https://t.co/loI4cLBB1O https://t.co/loI4cLBB1O